Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/08/77/ed/0877eda4-cbb1-bace-3644-e73fb7aced4f/mza_1512576652754283542.jpeg/600x600bb.jpg
NETCast
Podcasting4Associations
37 episodes
2 months ago

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. 

Visit us at

https://nanets.net/

Show more...
Medicine
Business,
Non-Profit,
Health & Fitness
RSS
All content for NETCast is the property of Podcasting4Associations and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. 

Visit us at

https://nanets.net/

Show more...
Medicine
Business,
Non-Profit,
Health & Fitness
https://content.production.cdn.art19.com/images/8a/e7/2d/72/8ae72d72-ca95-4125-b0f4-7d60408b5f0f/3e9eeabec911a1a22d69d2cb633688ea5d6900a9fe03ba2edd183293f490ddf06cfc3e4f67d5608f0148da35a4af9c3c66620f4f3ed64d9af8c0628790944fdb.jpeg
Promising Advances in NEC Research and Treatment
NETCast
37 minutes 44 seconds
5 months ago
Promising Advances in NEC Research and Treatment
In this podcast, Dr. Garima Gupta meets with Dr. Renuka Iyer and Dr. Aman Chauhan to discuss the latest advancements in the treatment of neuroendocrine carcinomas, focusing on the differences between pulmonary and extra pulmonary types, treatment strategies for extensive stage cases, and the challenges faced in treating platinum refractory patients. They highlight the importance of clinical trials and innovative therapies, including DLL3 targeting and oncolytic virus studies, while emphasizing the need for ongoing research and patient participation in trials. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
NETCast

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more. 

Visit us at

https://nanets.net/